Prospective monocentric study, non-randomized of the detection of sarcopenia in clinical practice in patients with ovarian or endometrial cancer requiring systemic oncological treatment.
main question : Identify the criteria correlated with the presence of sarcopenia (defined by the measurement of the IMS by the CT-X method in L3) among the impedancemetry and the HAS malnutrition criteria.
Data collection will be done at 6 months, 12 months after the date of inclusion.
Patients at least 18 years old
Patient presenting with a diagnosis of cancer of ovarian origin with an indication for chemotherapy
Patient with a diagnosis of endometrial cancer with an indication for chemotherapy
Patient with no diagnosis of other types of cancer in the previous five years
Patient with cancer of ovarian origin not requiring chemotherapy treatment
Patient with endometrial cancer not requiring chemotherapy treatment
Discovery of an intercurrent cancer other than skin or cervix cancers.
Patient wearing a Pace maker